JP2928727B2 - Method for treating cultured skin for storage and transportation - Google Patents

Method for treating cultured skin for storage and transportation

Info

Publication number
JP2928727B2
JP2928727B2 JP6198071A JP19807194A JP2928727B2 JP 2928727 B2 JP2928727 B2 JP 2928727B2 JP 6198071 A JP6198071 A JP 6198071A JP 19807194 A JP19807194 A JP 19807194A JP 2928727 B2 JP2928727 B2 JP 2928727B2
Authority
JP
Japan
Prior art keywords
gelatin
cultured skin
skin
layer
transportation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP6198071A
Other languages
Japanese (ja)
Other versions
JPH0823968A (en
Inventor
勝保 諸田
真一郎 森田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gunze Ltd
Original Assignee
Gunze Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunze Ltd filed Critical Gunze Ltd
Priority to JP6198071A priority Critical patent/JP2928727B2/en
Publication of JPH0823968A publication Critical patent/JPH0823968A/en
Application granted granted Critical
Publication of JP2928727B2 publication Critical patent/JP2928727B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、保存、輸送に適する培
養皮膚の処理方法に関する。
The present invention relates to a method for treating cultured skin suitable for storage and transportation.

【0002】[0002]

【従来の技術】新規に開発された医薬、化粧品等に関し
ては皮膚への刺激性、毒性等を判定するために動物によ
る各種実験が行われているが、一方では近時の動物愛護
の観点から、また、より人体に近い実験へのニーズか
ら、更には、均質な材料の安定的供給の観点から、人体
の皮膚モデルに関する研究が行われている。かかる皮膚
モデルとしては、例えば、コラーゲンスポンジに人体細
胞を播種して培養したもの、生細胞からなるもの、或
は、表皮、真皮の二層構造に培養されたもの等種々ある
が、何れも物理的強度が極めて弱く、軽い衝撃等で簡単
に破損したり剥離したりするため、特に、保存、輸送等
の面において問題があった。即ち、培養液に浸漬した状
態で取り扱う従来法にあっては、振動等による破損、或
は、培養液が容器からこぼれたりする等の問題を有し
た。また、アガロース(寒天)を用いて固定する方法も
あるが、かかるアガロースのゾル化には50℃という高
温を要するため、細胞が死滅したり、或は、ゲル強度が
強過ぎるため、培養皮膚を取り出す際に破損しやすいと
いう問題がある。
2. Description of the Related Art Various experiments with animals have been conducted to determine the irritation and toxicity to the skin of newly developed medicines and cosmetics, but on the other hand, from the viewpoint of recent animal welfare. In addition, research on a human skin model has been conducted in view of the need for an experiment closer to the human body and from the viewpoint of stable supply of a homogeneous material. As such a skin model, for example, there are various types such as a model in which human cells are seeded and cultured on a collagen sponge, a model consisting of living cells, or a model cultured in a two-layer structure of epidermis and dermis. Since the mechanical strength is extremely weak and the material is easily damaged or peeled off by a light impact or the like, there is a problem particularly in terms of storage and transportation. That is, the conventional method in which the culture solution is immersed in the culture solution has problems such as breakage due to vibration or the like, or the culture solution spilling out of the container. There is also a method of fixing using agarose (agar). However, since the agarose requires a high temperature of 50 ° C., cells are killed or the gel strength is too strong. There is a problem that it is easily damaged when it is taken out.

【0003】[0003]

【発明が解決しようとする課題】本発明は、かかる点、
特に、保存、輸送等に適し、振動、収納容器の転倒にお
いても液がこぼれたり、また、培養皮膚自体が破損した
り、或は、細胞が死滅したり、変質したりすることのな
い新規な固定方法を提供するものである。
SUMMARY OF THE INVENTION The present invention provides
In particular, it is suitable for storage, transportation, etc., and is a novel type that does not spill liquid even when it is shaken or the storage container is overturned, and that the cultured skin itself is not damaged, or the cells are not killed or deteriorated. It provides a fixing method.

【0004】[0004]

【課題を解決するための手段】 即ち、本発明は、昇温
してゾル化したゼラチン溶液中に、表皮層と真皮層の二
層構造よりなる培養皮膚を、表皮層は気相に接しかつ真
皮層はゼラチン溶液中に接するよう配置させ、然る後に
これを降温してゲル化させ、かかるゲル化したゼラチン
によって配置させた培養皮膚を固定すること、また、ゼ
ラチンの溶媒として細胞培養液を用いること、更に、前
記表皮層と真皮層の二層構造よりなる培養皮膚をゼラチ
ンから取り出す際、ゲル化したゼラチンを昇温してゾル
化させ、ゼラチンを低粘度の状態にして培養皮膚を取り
出すことをそれぞれ特徴とする保存、輸送に供する培養
皮膚の処理方法に関する。
That is, the present invention relates to a method for preparing a cultured skin having a two-layer structure of an epidermis layer and a dermis layer in a gelatin solution which has been heated to a sol, wherein the epidermis layer is in contact with the gas phase and The dermis layer is placed in contact with the gelatin solution, and then the temperature is lowered to gel, and the cultured skin placed with the gelatinized gelatin is fixed, and the cell culture solution is used as a solvent for gelatin. Further, when taking out the cultured skin having a two-layer structure of the epidermis layer and the dermis layer from gelatin, the gelatinized gelatin is heated to form a sol, the gelatin is brought into a low viscosity state, and the cultured skin is taken out. And a method for treating cultured skin for storage and transportation.

【0005】[0005]

【作用】本発明によれば、ゾル状態にあるゼラチン中に
培養皮膚を入れ、これをゲル化することによってゼリー
化したゼラチンによってその周囲を固定、保持するた
め、例えば、振動、横転、反転等してもかかる培養皮膚
がゼラチン面から移動したり剥れることがない。また、
ゼラチン自体高粘度化しているため、容器からこぼれる
こともない。従って、通常の取扱い、或は、輸送時等に
おける従来のトラブルが解消する。また、該ゼラチンの
溶媒として細胞培養液を用いることによって保存、輸送
中に必要な栄養源が確保され、細胞が死滅したり変質す
ることなく長期に安定している。また、特に、表皮と真
皮の二層構造より成る培養皮膚においては、表皮は気相
に、真皮は栄養補給層、即ち、培地に接していなけれ
ば、ふやけ、細胞の死滅というようなトラブルを生じる
が、本発明方法によればかかる問題を生ずることがな
い。
According to the present invention, a cultured skin is put in gelatin in a sol state, and the surroundings are fixed and held by gelatin gelled by gelling the cultured skin. However, such cultured skin does not move or peel off from the gelatin surface. Also,
Since the gelatin itself has a high viscosity, it does not spill from the container. Therefore, conventional troubles during normal handling or during transportation are eliminated. In addition, by using a cell culture solution as a solvent for the gelatin, a necessary nutrient source is secured during storage and transportation, and the cells are stable for a long time without being killed or deteriorated. In particular, in the case of cultured skin consisting of a two-layer structure of the epidermis and the dermis, the epidermis is in the gas phase, and the dermis causes troubles such as swelling and cell death if not in contact with the nutrient supply layer, that is, the medium. However, according to the method of the present invention, such a problem does not occur.

【0006】本発明に用いられるゼラチンは、豚、牛等
の動物の皮、腱、靭帯、筋膜等より抽出されるもので、
ゾル−ゲル転移点が20〜35℃の範囲にあるものであ
ればその由来を特に問わない。従って、にかわのような
ものであってもよい。かかるゼラチンの濃度は溶媒に対
し1〜20重量%、好ましくは5〜10重量%の範囲に
あることが、ゾル状態の粘度、ゲル化に要する時間、形
成されるゲルの強度等の点において望ましい。即ち、使
用濃度が高すぎるとゾル状態での粘度及び、ゲル状態で
の強度が高過ぎるため固定作業、及び、取り出しの際の
損傷等の問題があり、逆に使用濃度が低過ぎるとゲル化
に時間を要し、また、保持性に劣る問題がある。また、
これの溶媒としては、保存、輸送時等における栄養を確
保するため、例えば、細胞培養液であるDME+5%血
清培地等をそのまま用いるのが好適であるが、適宜栄養
源を添加してもよい。
The gelatin used in the present invention is extracted from the skin, tendon, ligament, fascia and the like of animals such as pigs and cows.
The origin is not particularly limited as long as the sol-gel transition point is in the range of 20 to 35 ° C. Therefore, it may be something like glue. The concentration of the gelatin is preferably in the range of 1 to 20% by weight, preferably 5 to 10% by weight based on the solvent, in view of the viscosity in the sol state, the time required for gelation, the strength of the formed gel, and the like. . That is, if the use concentration is too high, the viscosity in the sol state and the strength in the gel state are too high, so there are problems such as fixing work, and damage at the time of removal, and conversely, if the use concentration is too low, gelation occurs. It takes a long time, and there is a problem that the retention is inferior. Also,
As a solvent for this purpose, for example, DME + 5% serum medium, which is a cell culture solution, is preferably used as it is in order to ensure nutrients during storage and transportation, but a nutrient source may be added as appropriate.

【0007】一方、本発明に適用可能な培養皮膚の好例
として、例えば、コラーゲンスポンジに真皮線維芽細胞
を播種し、しかる後にこの上に表皮角化細胞を播種する
ことによって製造される毒性試験、或は、創傷治療用の
人工皮膚等に適用されるものが例示できるが、特に、こ
れに限定されるものではなく単層より成るものであって
も良い。かかる培養皮膚とゼラチンゲルとの一体化に際
しては、培養に汎用される透明な蓋付きの容器に加熱し
てゾル化したゼラチンを適量入れ、次いで、培養皮膚を
その中心に位置させ、必要量のゼラチン中に埋没させた
後、ゲル化温度まで冷却して固定させても、容器の中心
に培養皮膚を位置させ、これに必要量のゾル化したゼラ
チンを注ぎ込み、その後ゲル化温度まで冷却して固定さ
せても何れでも良い。しかる後は、極端な低温、例え
ば、培養皮膚の細胞が剥れないよう10℃以上、また、
逆にゾル化して保持力が低下したり、細胞が死滅するこ
とのないよう37℃以下の温度を維持して管理する。ま
た、これの使用に際しては、ゲル化したゼラチンから直
接培養皮膚を取り出してもよいが、損傷等を防止する意
味において温度を高めてゼラチンをゾル化し、低粘度の
状態で取り出すのが好ましい。この際ゼラチンが付着し
ているような場合には生理食塩水等で洗浄するのが望ま
しい。
On the other hand, as a good example of the cultured skin applicable to the present invention, for example, a toxicity test produced by disseminating dermal fibroblasts on a collagen sponge, and thereafter disseminating epidermal keratinocytes thereon, Alternatively, a material applied to an artificial skin or the like for treating a wound can be exemplified. However, the material is not particularly limited thereto, and may be a single layer. When integrating the cultured skin with the gelatin gel, an appropriate amount of heated and solated gelatin is placed in a transparent lidded container commonly used for culturing, and then the cultured skin is positioned at the center, and the required amount of Even after being buried in gelatin, even if it is cooled down to the gelation temperature and fixed, place the cultured skin in the center of the container, pour the required amount of gelatinized sol into this, and then cool to the gelation temperature. It may be fixed or any. After that, extremely low temperature, for example, 10 ℃ or more so that the cells of the cultured skin do not peel off,
Conversely, the temperature is maintained at a temperature of 37 ° C. or less so that the sol is not formed and the holding power is reduced and the cells are not killed. When using this, the cultured skin may be taken out directly from the gelatinized gelatin, but it is preferable to take out the gelatin in a low viscosity state by raising the temperature to a sol in order to prevent damage and the like. At this time, when gelatin is adhered, it is desirable to wash with a physiological saline or the like.

【0008】[0008]

【実施例】以下、本発明について実施例を挙げて説明す
る。 1.皮膚モデルのゼラチンへの固定 (1)皮膚モデルの調整 24ウエル培養プレートの底面に架橋し、凍結乾燥した
ポアサイズ90μm、厚さ3mmのTypeIコラーゲ
ンから成るスポンジを敷き、ヒト線維芽細胞をKGM+
10%血清培地に懸濁し、1平方センチ当り100万c
ellsの濃度で播種し、細胞が完全に基材に接着する
まで37℃で1晩培養した。次いで、このスポンジ上に
ポアサイズ15μm、厚さ40μmのTypeIコラー
ゲンから成る架橋、凍結乾燥され、シート状にプレスさ
れたスポンジシートを敷き、ヒト角化細胞をKGM+1
0%血清培地に懸濁し、1平方センチ当り80万cel
lsの濃度で播種し、37℃で1晩培養して表皮層と真
皮層の二層構造からなる皮膚モデルを作成した。 (2)ゼラチン溶液の調整 溶媒としてのDME+5%血清培地100mlを37℃
に保ち、これにEOG滅菌したウシ骨由来のゼラチン粉
末10gを加え、攪拌、溶解して10%ゼラチンゾル溶
液を調整した。かかる液は水のようにさらさらした低粘
度のゾルであった。 (3)ゲルへの封入 (1)で調整した皮膚モデルを6ウエルプレートの中心
に置き、このまわりに(2)で調整したゼラチンゾルを
3ml加えた。この液量では皮膚モデル表面の表皮層は
気相、即ち、空気に接し、真皮層はゼラチン液中に保た
れていた。これを室温(約20℃)で放置したところ約
30分後にはゲル化し、ゼリー状の高粘度のゼラチンに
よってかかる皮膚モデルは固定された。 2.保存、輸送の確認試験 前記のように固定した培養皮膚モデルが保存、輸送に耐
え得るかどうかを確認するため37℃で培養を続けた皮
膚モデルをコントロールとし、ゲル封入後1,3,5日
間室温(20℃)で放置した本発明モデルの細胞数をニ
ュートラルレッド法で計測した。その結果、1日後9
7.7%、3日後101.8%、5日後102.0%
(但し、37℃のモデルを100としたとき)の値を得
た。これは、この間に細胞の状態が常に正常に維持され
たことを示したものである。また、同時に5日後のモデ
ルの組織切片を作成し、観察したところ大きな構造の変
化がなかったことが確認できた。更に、取り扱い上、ゼ
ラチンゲルで固定された培養皮膚はそのままの状態を維
持し、剥離したり損傷することがなかった。
The present invention will be described below with reference to examples. 1. Fixation of Skin Model to Gelatin (1) Preparation of Skin Model A sponge made of Type I collagen having a cross-linked and freeze-dried pore size of 90 μm and a thickness of 3 mm was spread on the bottom of a 24-well culture plate, and human fibroblasts were subjected to KGM +
Suspended in 10% serum medium, 1 million c / cm 2
The cells were seeded at a concentration of ells and cultured overnight at 37 ° C. until the cells completely adhered to the substrate. Next, a sponge sheet formed of a cross-linked, freeze-dried, and pressed sheet of Type I collagen having a pore size of 15 μm and a thickness of 40 μm was spread on the sponge, and human keratinocytes were subjected to KGM + 1.
Suspended in 0% serum medium, 800,000 cells per square centimeter
The cells were seeded at a concentration of ls and cultured overnight at 37 ° C. to prepare a skin model having a two-layer structure of an epidermis layer and a dermis layer. (2) Preparation of gelatin solution 100 ml of DME + 5% serum medium as a solvent at 37 ° C.
Was added thereto, and 10 g of EOG-sterilized bovine bone-derived gelatin powder was added thereto, followed by stirring and dissolving to prepare a 10% gelatin sol solution. The liquid was a low-viscosity sol that was free flowing like water. (3) Encapsulation in Gel The skin model prepared in (1) was placed at the center of a 6-well plate, and around this, 3 ml of the gelatin sol prepared in (2) was added. With this liquid volume, the epidermis layer on the skin model surface was in contact with the gas phase, that is, air, and the dermis layer was kept in the gelatin solution. When this was left at room temperature (about 20 ° C.), it gelled after about 30 minutes, and the skin model was fixed by jelly-like high-viscosity gelatin. 2. Confirmation test of storage and transport In order to confirm whether the cultured skin model fixed as described above can withstand storage and transport, a skin model cultured at 37 ° C. was used as a control and 1, 3, 5 days after gel inclusion. The number of cells of the model of the present invention left at room temperature (20 ° C.) was counted by the neutral red method. As a result, one day later 9
7.7%, 101.8% after 3 days, 102.0% after 5 days
(However, when the model at 37 ° C. is set to 100). This indicates that the state of the cells was constantly maintained during this period. At the same time, a tissue section of the model 5 days later was prepared and observed. As a result, no significant structural change was confirmed. Furthermore, in handling, the cultured skin fixed with gelatin gel was maintained as it was, and was not peeled or damaged.

【0009】[0009]

【発明の効果】本発明は、上記のように20〜35℃の
温度範囲においてゲルとゾルに可逆的に変化するゼラチ
ンの性質を利用し、高粘度のゲル状態にあるゼラチンに
よって培養皮膚を固定、保持するため、輸送、取り扱い
時にこれが損傷したり、変質する等のトラブルを生じな
い。また、細胞培養液を溶媒として用いたり、適宜の栄
養源をこれに加えることによって細胞の成育状態を維持
できること、更に、ゾル、ゲル化の温度が細胞が死滅し
たり、損傷するほどの高温、低温を要しないこと等極め
て適しており、出荷時までの保存、或は、輸送、更に
は、そのための作業性等において優れた効果を発揮する
ものである。また、予め無底のセル等の容器に皮膚培養
を行えば、ゼラチン溶液への移し替えにおいてこれをそ
のまま移設したり、容器をそのまま固定してゼラチンを
注ぎ込むこともでき、作業が容易であるばかりか、これ
に伴う損傷等も防止できる。更に、前記したように該ゼ
ラチン自体細胞培養液を溶媒として、十分培地となり得
ることから当初よりこれを培地として皮膚培養を行え
ば、一旦培養された培養皮膚をこれに移し替える必要が
なく、その作業がより合理的であると共に、移し替えに
伴う損傷等の懸念が更に解消されるものである。
The present invention utilizes the property of gelatin that reversibly changes into a gel and a sol in the temperature range of 20 to 35 ° C. as described above, and fixes cultured skin with gelatin in a gel state having a high viscosity. Since it is held, it does not cause trouble such as damage or deterioration during transportation and handling. In addition, the cell culture solution can be used as a solvent, or the growth state of the cells can be maintained by adding an appropriate nutrient thereto, and further, the sol and gelation temperatures are high enough to kill or damage the cells. It is extremely suitable because it does not require a low temperature, and exhibits excellent effects in storage until shipping, transportation, and workability therefor. Also, if skin culture is carried out in advance in a container such as a cell without a bottom, it is possible to transfer the gelatin solution as it is, or fix the container as it is and pour gelatin into it, making the operation easier. Alternatively, damage and the like accompanying this can be prevented. Furthermore, as described above, since the gelatin itself can be used as a solvent and a sufficient culture medium can be used as a solvent, if skin culture is performed using this as a culture medium from the beginning, it is not necessary to transfer the cultured skin once cultured to this. The work is more rational, and concerns about damage due to relocation are further eliminated.

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 昇温してゾル化したゼラチン溶液中
に、表皮層と真皮層の二層構造よりなる培養皮膚を、表
皮層は気相に接しかつ真皮層はゼラチン溶液中に接する
よう配置させ、然る後にこれを降温してゲル化させ、か
かるゲル化したゼラチンによって配置させた培養皮膚を
固定することを特徴とする保存、輸送に供する培養皮膚
の処理方法。
1. A cultured skin having a two-layer structure of an epidermis layer and a dermis layer is placed in a gelatin solution that has been heated to a sol, so that the epidermis layer is in contact with the gas phase and the dermis layer is in contact with the gelatin solution. A method for treating cultured skin for storage and transportation, characterized in that the temperature is then lowered and gelled, and the cultured skin arranged with the gelled gelatin is fixed.
【請求項2】 ゼラチンの溶媒として細胞培養液を
用いることを特徴とする請求項1に記載の処理方法。
2. The method according to claim 1, wherein a cell culture solution is used as a gelatin solvent.
【請求項3】 前記表皮層と真皮層の二層構造より
なる培養皮膚をゼラチンから取り出す際、ゲル化したゼ
ラチンを昇温してゾル化させ、ゼラチンを低粘度の状態
にして培養皮膚を取り出すことを特徴とする請求項1又
は請求項2に記載の処理方法。
3. When taking out the cultured skin having the two-layer structure of the epidermis layer and the dermis layer from the gelatin, the gelatinized gelatin is heated to form a sol, the gelatin is brought into a low viscosity state, and the cultured skin is taken out. The processing method according to claim 1 or 2, wherein:
JP6198071A 1994-07-18 1994-07-18 Method for treating cultured skin for storage and transportation Expired - Lifetime JP2928727B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6198071A JP2928727B2 (en) 1994-07-18 1994-07-18 Method for treating cultured skin for storage and transportation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6198071A JP2928727B2 (en) 1994-07-18 1994-07-18 Method for treating cultured skin for storage and transportation

Publications (2)

Publication Number Publication Date
JPH0823968A JPH0823968A (en) 1996-01-30
JP2928727B2 true JP2928727B2 (en) 1999-08-03

Family

ID=16385044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6198071A Expired - Lifetime JP2928727B2 (en) 1994-07-18 1994-07-18 Method for treating cultured skin for storage and transportation

Country Status (1)

Country Link
JP (1) JP2928727B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001050851A3 (en) * 2000-01-14 2001-12-27 Biolife Solutions Inc Storage of cells, tissues and organs in gel-based media

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5237714B2 (en) * 2008-07-29 2013-07-17 BioROIS株式会社 Cell transport carrier and cell transport method using the same
US10655120B2 (en) 2011-03-21 2020-05-19 The University Of Newcastle Upon Tyne Transport of cells in hydrogels
WO2013137426A1 (en) * 2012-03-16 2013-09-19 テルモ株式会社 Liquid composition for transporting sheet-like structure
EP3406713A4 (en) * 2016-03-28 2019-09-25 Terumo Kabushiki Kaisha Method and device for keeping shape of fragile material in liquid
CN109071628A (en) * 2016-03-29 2018-12-21 富士胶片株式会社 Cell sheet embedding medium, composition and kit containing cell sheet
WO2017170343A1 (en) * 2016-03-29 2017-10-05 富士フイルム株式会社 Laminate body containing cell sheet, heart disease therapeutic agent and film for cell sheet lamination
US20230089316A1 (en) * 2020-02-21 2023-03-23 Jbm Incorporation Biomaterial preserving composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001050851A3 (en) * 2000-01-14 2001-12-27 Biolife Solutions Inc Storage of cells, tissues and organs in gel-based media

Also Published As

Publication number Publication date
JPH0823968A (en) 1996-01-30

Similar Documents

Publication Publication Date Title
US4837285A (en) Collagen matrix beads for soft tissue repair
US5830507A (en) Biotherapeutic cell-coated microspheres
EP0107055B1 (en) Artificial organs or membranes for medical use
US4642120A (en) Repair of cartilage and bones
CA2731082C (en) Tissue scaffold comprising an acellular tissue matrix and sodium acetate
JPS61502129A (en) Biodegradable matrix and its manufacturing method
EP1496824A2 (en) Tissue composites and uses thereof
US20070269792A1 (en) Cross-linked collagen matrix for producing a skin equivalent
PT87084B (en) METHOD FOR PRODUCING A SKIN EQUIVALENT AND SKIN EQUIVALENT OBTAINED BY THAT PROCESS
JP2928727B2 (en) Method for treating cultured skin for storage and transportation
JPS62246371A (en) Artificial skin and its production
JP2005537845A (en) Fibrin cell support and method of use thereof
US20210001005A1 (en) Method for producing collagen vitrigel, method for producing purified collagen vitrigel, and collagen vitrigel and purified collagen vitrigel produced by said methods
Lai Influence of solvent composition on the performance of carbodiimide cross-linked gelatin carriers for retinal sheet delivery
WO1992010217A1 (en) Wound dressings and processes for manufacture thereof
US9259445B2 (en) Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
JP2004520828A (en) Method for producing cryopreserved composite biological construct and product obtained from the method
JP3025931B2 (en) Liquid for cryopreservation of epidermal cell sheet
JPH05503930A (en) Low-temperature preservation of cultured epithelial cell sheets
Senthilkumar et al. Engraftment and proliferation of thermoreversible-gelation-polymer-encapsulated human corneal limbal-stem-cells on ocular surface of a cadaver cornea
JPS6242913A (en) Skin care cosmetic composition and manufacture
TWI264306B (en) Wound dressings and their preparation
WO2007141028A2 (en) Integrated implant system (iis) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
JP2002336344A (en) Culture cell sheet package and method of fabrication for the same
JP6228176B2 (en) Gelatin or chemical modification thereof, aqueous composition containing the same and medical laminate, and method for producing medical laminate and cell sheet isolation method

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080514

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090514

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100514

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110514

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110514

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120514

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120514

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 14

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 14

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 14

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140514

Year of fee payment: 15

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term